rosiglitazone has been researched along with Intraepithelial Prostatic Neoplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boone, B; Cai, H; Fernandez, S; Hayward, SW; He, Y; Jerome, WG; Jiang, M; Magnuson, MA; Matusik, RJ; Roy-Burman, P; Shappell, SB; Yi, Y; Yu, X | 1 |
1 other study(ies) available for rosiglitazone and Intraepithelial Prostatic Neoplasia
Article | Year |
---|---|
Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.
Topics: Animals; Autophagy; Cell Line; Epithelial Cells; Gene Expression Profiling; Hypoglycemic Agents; Male; Mice; Mice, SCID; Mice, Transgenic; Molecular Sequence Data; Phenotype; PPAR gamma; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Isoforms; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transplantation, Heterologous | 2010 |